silybin has been researched along with Cognitive Decline in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Huo, Q; Qi, Y; Shi, Y; Sui, H; Zhao, L | 1 |
| Cao, J; Chen, YX; Dong, Y; Gao, H; Gu, Z; Jin, G; Li, X; Na, X; Su, Y; Wang, S; Wei, P; Wei, X; Yin, H; Yuan, J | 1 |
| Haddadi, R; Komaki, A; Mahboobian, MM; Makhdoomi, S; Mohammadi, M | 1 |
| Cui, L; Hattori, S; Hayashi, T; Ikejima, T; Liu, B; Liu, P; Liu, W; Mizuno, K; Onodera, S; Ushiki-Kaku, Y | 1 |
| Fu, J; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, W; Liu, X; Mizuno, K; Song, S; Wang, C | 1 |
| Bai, D; Chen, X; Cui, Y; Jin, G; Li, W; Liu, X; Sun, Y; Wang, M; Zhang, D; Zhang, L; Zhao, L; Zhu, L; Zhu, Q | 1 |
6 other study(ies) available for silybin and Cognitive Decline
| Article | Year |
|---|---|
Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of Aβ aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Biomimetics; Cognitive Dysfunction; Disease Models, Animal; Exosomes; Macrophages; Mice; Neurodegenerative Diseases; Silybin | 2021 |
Silibinin Ameliorates Formaldehyde-Induced Cognitive Impairment by Inhibiting Oxidative Stress.
Topics: Alzheimer Disease; Animals; Antioxidants; Cognitive Dysfunction; Formaldehyde; Glycogen Synthase Kinase 3 beta; Hippocampus; Memory Disorders; Mice; NF-E2-Related Factor 2; Oxidative Stress; Silybin; Silybum marianum; Silymarin | 2022 |
Silibinin-loaded nanostructured lipid carriers (NLCs) ameliorated cognitive deficits and oxidative damages in aluminum chloride-induced neurotoxicity in male mice.
Topics: Aluminum Chloride; Animals; Antioxidants; Cognition; Cognitive Dysfunction; Drug Carriers; Lipids; Male; Mice; Nanostructures; Neurodegenerative Diseases; Neurotoxicity Syndromes; Oxidative Stress; Particle Size; Silybin | 2022 |
Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
Topics: Animals; Apoptosis; Cerebral Cortex; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Hippocampus; Insulin; Insulin-Like Growth Factor I; Male; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Phosphorylation; Rats; Signal Transduction; Silybin; Streptozocin; tau Proteins | 2020 |
Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; alpha-Synuclein; Animals; Apoptosis; Cerebral Cortex; Cognitive Dysfunction; Hippocampus; Male; Memantine; Mice, Inbred C57BL; Mitochondria; Mitochondrial Diseases; Morris Water Maze Test; Neurons; Neuroprotective Agents; Open Field Test; Oxidative Stress; Parkinsonian Disorders; Silybin | 2021 |
Natural silibinin modulates amyloid precursor protein processing and amyloid-β protein clearance in APP/PS1 mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Cognitive Dysfunction; Disease Models, Animal; Down-Regulation; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Silybin; Up-Regulation | 2019 |